Aradhye Shreeram 4
4 · Dicerna Pharmaceuticals Inc · Filed Dec 17, 2021
Insider Transaction Report
Form 4
Aradhye Shreeram
EVP & Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2021-12-15$38.05/sh−833$31,696→ 6,973 total - Exercise/Conversion
Common Stock
2021-12-15+2,837→ 7,806 total - Exercise/Conversion
Restricted Stock Units
2021-12-15−2,837→ 8,513 total→ Common Stock (2,837 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
- [F3]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.